Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nC-001 in chronic euvolemic hyponatremia
NCT06798675Phase 2Not yet recruiting
- Sponsor
- Nephcentric
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of NC001 in Euvolemic hyponatremia (3 arms), sponsored by Nephcentric. Primary endpoint: Serum Urea and Sodium (Na). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
NC001
03
Conditions
Euvolemic hyponatremia
Beyond the preview
Go deeper on NCT06798675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798675.